دورية أكاديمية
Exploring the in-silico approach for assessing the potential of natural compounds as a SARS-CoV-2 main protease inhibitors.
| العنوان: | Exploring the in-silico approach for assessing the potential of natural compounds as a SARS-CoV-2 main protease inhibitors. |
|---|---|
| المؤلفون: | Patel, Ashish1 aashishpatel2388@gmail.com, Patel, Alkesh1, Hemani, Rahul1, Solanki, Riddhi1, Kansara, Janki1, Patel, Gargi1, Pradhan, Sayantan2, Bambharoliya, Tushar3 |
| المصدر: | Organic Communications. Jan-Mar2021, Vol. 14 Issue 1, p58-72. 15p. |
| مصطلحات موضوعية: | *SARS-CoV-2, *COVID-19 pandemic, *PROTEASE inhibitors, *VIRUS diseases, *COVID-19, *BERBERINE, *CATECHIN |
| مستخلص: | The SARS-CoV-2 virus emerged as a major cause of the COVID-19 pandemic in December 2019. Many attempts have been made to block the viral infection by targeting various processes like its entry, uncoating, replication, activating T cells response, and rising antibody titer. Also, many drugs are repurposed like remdesivir, dexamethasone, tocilizumab, hydroxychloroquine based on their established therapeutic efficacy against other viruses in the past. Natural products (NP) consist of a promising candidate and are needed to evaluate those molecules with molecular docking for preliminary screening and in vitro studies. Therefore, in the present study, a total of 12 active constituents from natural products like Ashwagandha, Tinospora cordifolia, Tea, Neem and lemon balm were docked, using the Autodock tool, onto the crystal structure of SARS CoV-2 main protease (PDB ID-5R80), to study their capability to act as main protease (Mpro) COVID-19 inhibitors. All NPs derivatives displayed good binding energies (ΔG) ranging from -8.8 to -5.2 kcal/mol, but berberine, epicatechin, and rosmarinic acid were found most potent, among others. Therefore, good binding energy, druglikeness, and efficient pharmacokinetics suggest the potential of NPs derivatives as SARS-CoV-2 main protease (Mpro) inhibitors. However, further research is necessary to investigate the ability of these compounds as COVID-19 inhibitors. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: | Academic Search Index |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
asx Academic Search Index 149539824 1295 6 Academic Journal academicJournal 1295.46887207031 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=149539824&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:asx&genre=article&issn=13076175&ISBN=&volume=14&issue=1&date=20210101&spage=58&pages=58-72&title=Organic Communications&atitle=Exploring%20the%20in-silico%20approach%20for%20assessing%20the%20potential%20of%20natural%20compounds%20as%20a%20SARS-CoV-2%20main%20protease%20inhibitors.&id=DOI:10.25135/acg.oc.97.2012.1895 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Exploring the in-silico approach for assessing the potential of natural compounds as a SARS-CoV-2 main protease inhibitors.
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Patel%2C+Ashish%22">Patel, Ashish</searchLink><relatesTo>1</relatesTo><i> aashishpatel2388@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Patel%2C+Alkesh%22">Patel, Alkesh</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hemani%2C+Rahul%22">Hemani, Rahul</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Solanki%2C+Riddhi%22">Solanki, Riddhi</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Kansara%2C+Janki%22">Kansara, Janki</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Patel%2C+Gargi%22">Patel, Gargi</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Pradhan%2C+Sayantan%22">Pradhan, Sayantan</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Bambharoliya%2C+Tushar%22">Bambharoliya, Tushar</searchLink><relatesTo>3</relatesTo> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <searchLink fieldCode="JN" term="%22Organic+Communications%22">Organic Communications</searchLink>. Jan-Mar2021, Vol. 14 Issue 1, p58-72. 15p. ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => *<searchLink fieldCode="DE" term="%22SARS-CoV-2%22">SARS-CoV-2</searchLink><br />*<searchLink fieldCode="DE" term="%22COVID-19+pandemic%22">COVID-19 pandemic</searchLink><br />*<searchLink fieldCode="DE" term="%22PROTEASE+inhibitors%22">PROTEASE inhibitors</searchLink><br />*<searchLink fieldCode="DE" term="%22VIRUS+diseases%22">VIRUS diseases</searchLink><br />*<searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br />*<searchLink fieldCode="DE" term="%22BERBERINE%22">BERBERINE</searchLink><br />*<searchLink fieldCode="DE" term="%22CATECHIN%22">CATECHIN</searchLink> ) Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => The SARS-CoV-2 virus emerged as a major cause of the COVID-19 pandemic in December 2019. Many attempts have been made to block the viral infection by targeting various processes like its entry, uncoating, replication, activating T cells response, and rising antibody titer. Also, many drugs are repurposed like remdesivir, dexamethasone, tocilizumab, hydroxychloroquine based on their established therapeutic efficacy against other viruses in the past. Natural products (NP) consist of a promising candidate and are needed to evaluate those molecules with molecular docking for preliminary screening and in vitro studies. Therefore, in the present study, a total of 12 active constituents from natural products like Ashwagandha, Tinospora cordifolia, Tea, Neem and lemon balm were docked, using the Autodock tool, onto the crystal structure of SARS CoV-2 main protease (PDB ID-5R80), to study their capability to act as main protease (Mpro) COVID-19 inhibitors. All NPs derivatives displayed good binding energies (ΔG) ranging from -8.8 to -5.2 kcal/mol, but berberine, epicatechin, and rosmarinic acid were found most potent, among others. Therefore, good binding energy, druglikeness, and efficient pharmacokinetics suggest the potential of NPs derivatives as SARS-CoV-2 main protease (Mpro) inhibitors. However, further research is necessary to investigate the ability of these compounds as COVID-19 inhibitors. [ABSTRACT FROM AUTHOR] ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.25135/acg.oc.97.2012.1895
)
)
[Languages] => Array
(
[0] => Array
(
[Code] => eng
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 15
[StartPage] => 58
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => SARS-CoV-2
[Type] => general
)
[1] => Array
(
[SubjectFull] => COVID-19 pandemic
[Type] => general
)
[2] => Array
(
[SubjectFull] => PROTEASE inhibitors
[Type] => general
)
[3] => Array
(
[SubjectFull] => VIRUS diseases
[Type] => general
)
[4] => Array
(
[SubjectFull] => COVID-19
[Type] => general
)
[5] => Array
(
[SubjectFull] => BERBERINE
[Type] => general
)
[6] => Array
(
[SubjectFull] => CATECHIN
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Exploring the in-silico approach for assessing the potential of natural compounds as a SARS-CoV-2 main protease inhibitors.
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Patel, Ashish
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Patel, Alkesh
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hemani, Rahul
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Solanki, Riddhi
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kansara, Janki
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Patel, Gargi
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pradhan, Sayantan
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bambharoliya, Tushar
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Text] => Jan-Mar2021
[Type] => published
[Y] => 2021
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 13076175
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 14
)
[1] => Array
(
[Type] => issue
[Value] => 1
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Organic Communications
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |